Free Trial

This company has been marked as potentially delisted and may not be actively trading.

CVE:BED

Bedrocan Cannabis (BED) Stock Price, News & Analysis

Bedrocan Cannabis logo

About Bedrocan Cannabis Stock (CVE:BED)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
171,120 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bedrocan Cannabis Corp., formerly POCML 2 Inc., is engaged in the import and sale of medicinal cannabis in Canada.

Receive BED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bedrocan Cannabis and its competitors with MarketBeat's FREE daily newsletter.

BED Stock News Headlines

Volatility Is Rising—But These 2 AI Stocks Could Thrive
2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.
See More Headlines

BED Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Bedrocan Cannabis investors own include Leaf Mobile (LEAF), Surna (SRNA), Canopy Growth (WEED), CannTrust (CTST), Canopy Growth (CGC), Jefferies Financial Group (JEF) and Largo Resources (LGO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
N/A
Industry
N/A
Sub-Industry
Cannabis
Current Symbol
CVE:BED
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (CVE:BED) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners